ROQUEFORT THERAPEUTICS PLC — Investor Relations & Filings
Roquefort Therapeutics PLC is a biotechnology company focused on developing next-generation, first-in-class medicines for hard-to-treat cancers. The company operates within the high-growth immuno-oncology market. Its portfolio consists of five novel, patent-protected, pre-clinical anti-cancer programs. These programs are designed to target cancers that have become resistant to existing therapies. Roquefort Therapeutics utilizes a distributed R&D model, combining its in-house expertise and laboratory facilities with a network of partnerships with leading academic cancer research centers to advance its development strategy.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Attendance at Endless Frontier Labs 2026 | 2026-05-07 | English | |
| Appointment of Non-Executive Director | 2026-05-07 | English | |
| Annual Report & Financial Statements | 2026-05-06 | English | |
| Clinical Trial Update | 2026-04-08 | English | |
| Total Voting Rights | 2026-04-01 | English | |
| Admission to Trading and First Day of Dealings | 2026-03-27 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 42454680 | Attendance at Endless Frontier Labs 2026 | 2026-05-07 | English | ||
| 42452990 | Appointment of Non-Executive Director | 2026-05-07 | English | ||
| 41725150 | Annual Report & Financial Statements | 2026-05-06 | English | ||
| 33885245 | Clinical Trial Update | 2026-04-08 | English | ||
| 33128296 | Total Voting Rights | 2026-04-01 | English | ||
| 33055516 | Admission to Trading and First Day of Dealings | 2026-03-27 | English | ||
| 33049112 | Investor Presentation | 2026-03-26 | English | ||
| 33048627 | Result of General Meeting | 2026-03-26 | English | ||
| 33037874 | Lyramid SPA & MK Cell License Update | 2026-03-25 | English | ||
| 32859708 | Proposed Acquisition and Fundraise of £8.5 million | 2026-03-02 | English | ||
| 32837809 | Transaction Update & Notice of Intention to Delist | 2026-02-25 | English | ||
| 12739673 | Research Note Published | 2026-01-15 | English | ||
|
2025
3 filings
| |||||
| 9889926 | Clinical Trial & License Agreement Update | 2025-12-12 | English | ||
| 9682762 | Conversion of CLNs | 2025-12-09 | English | ||
| 8963732 | Ex-Entitlement Date - Unlisted RNV Shares | 2025-12-01 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ROQUEFORT THERAPEUTICS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ROQUEFORT THERAPEUTICS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5061/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5061 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5061 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5061 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5061}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ROQUEFORT THERAPEUTICS PLC (id: 5061)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.